PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 10, 2026Diseases & Research0 citationsOpen Access

Radiotherapy in the Shadow of Shingles: Managing Non-Melanoma Skin Cancer in Postherpetic Fields

FKF. Zhang KevinBKByrnes KelceeYHYunfei Hu

Key Points

  • This study aims to explore the effectiveness of superficial radiotherapy for treating non-melanoma skin cancer in patients experiencing postherpetic neuralgia.
  • A case report of an 82-year-old male with biopsy-proven cSCC and PHN.
  • Superficial radiotherapy of 45 Gy in 15 fractions delivered over 3 weeks with standoff technique used.
  • Patient monitored for clinical response and side effects post-treatment.
  • Achieved complete clinical response at six months post radiotherapy.
  • No significant acute toxicity observed during treatment.
  • Patient tolerated treatment well despite underlying immunosuppression and other health issues.

Abstract

Cutaneous squamous cell carcinoma (cSCC) is a common form of non-melanoma skin cancer (NMSC), with incidence increasing in elderly and immunocompromised populations. Postherpetic neuralgia (PHN) is a chronic neuropathic pain condition that occurs following reactivation of the varicella–zoster virus and typically affects a single dermatome. In the skin, PHN occurs following re-infection with the varicella-zoster virus (VZV), also known as human herpesvirus-3 (HHV-3). It usually takes a dermatomal distribution. We report on the successful treatment of a 15 mm biopsy-proven painful and tender in-situ cutaneous squamous cell carcinoma (cSCC) arising within a symptomatic field of longstanding PHN in an 82-year-old male, immunosuppressed with chronic lymphocytic leukemia (CLL)and cognitive decline. Definitive superficial radiotherapy (SXRT) of 45 Gy in 15 fractions was delivered over 3 weeks, using a 5 mm standoff to avoid direct contact with hypersensitive skin. The patient tolerated treatment well and achieved a complete clinical response still present at six months post RT when death from other causes intervened with no significant acute toxicity. This case highlights the feasible use of SXRT for cSCC arising within a PHN-affected dermatomal field through applying stand off to reduce contact irritation during treatment.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kevin et al. (2026) studied this question.

synapsesocial.com/papers/6a0021b7c8f74e3340f9ca30https://doi.org/10.54457/dr.202602005
Ask AI
Helpful
Bookmark
Share
View Full Paper